TCM
PTCT icon

TimesSquare Capital Management’s PTC Therapeutics PTCT Stock Holding History

TimesSquare Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-572,353
Closed -$23.3M – 173
2023
Q2 		$23.3M Sell
572,353
-28,730
-5% -$1.41M 0.33% 116
2023
Q1 		$29.1M Sell
601,083
-58,457
-9% -$2.67M 0.43% 102
2022
Q4 		$25.2M Sell
659,540
-72,350
-10% -$3.01M 0.36% 116
2022
Q3 		$36.7M Buy
731,890
+45,990
+7% +$2.25M 0.51% 94
2022
Q2 		$27.5M Sell
685,900
-162,505
-19% -$5.7M 0.38% 117
2022
Q1 		$31.7M Sell
848,405
-234,500
-22% -$9.03M 0.36% 119
2021
Q4 		$43.1M Sell
1,082,905
-46,980
-4% -$1.8M 0.38% 114
2021
Q3 		$42M Sell
1,129,885
-23,900
-2% -$982K 0.37% 119
2021
Q2 		$48.8M Buy
1,153,785
+116,315
+11% +$4.98M 0.4% 107
2021
Q1 		$49.1M Sell
1,037,470
-14,398
-1% -$855K 0.42% 104
2020
Q4 		$64.2M Sell
1,051,868
-109,550
-9% -$6.46M 0.52% 78
2020
Q3 		$54.3M Buy
1,161,418
+165,723
+17% +$8.16M 0.51% 81
2020
Q2 		$50.5M Buy
995,695
+67,320
+7% +$3.31M 0.48% 89
2020
Q1 		$41.4M Buy
928,375
+301,105
+48% +$15.2M 0.49% 83
2019
Q4 		$30.1M Buy
+627,270
New +$26.7M 0.27% 151

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TimesSquare Capital Management's PTCT Position: Q3 2023 in Review

TimesSquare Capital Management sold out of PTC Therapeutics (PTCT) in Q3 2023, closing a stake of 572,353 shares — an estimated $23.3M sold.

TimesSquare Capital Management first reported a position in PTCT in Q4 2019 and held it in 15 quarters. The position peaked at $64.2M in Q4 2020. 179 funds tracked by Wall St. Rank hold PTCT as of Q3 2023.

  • TimesSquare Capital Management reported no remaining PTC Therapeutics position as of Q3 2023 after selling out during the quarter.
  • TimesSquare Capital Management sold 572,353 PTC Therapeutics shares in Q3 2023, an estimated $23.3M.
  • TimesSquare Capital Management first reported a position in PTC Therapeutics in Q4 2019 and held it in 15 quarters.
  • TimesSquare Capital Management's PTC Therapeutics position peaked at $64.2M in Q4 2020.
  • 179 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2023.

Based on TimesSquare Capital Management's 13F filing for Q3 2023, filed 17 Nov 2023.